Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Roche Holding AG Basel American Depositary Shares (OP: RHHBY )

34.43 -0.09 (-0.26%)
Streaming Delayed Price Updated: 10:02 AM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 224,422
Open 34.54
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 34.52
Today's Range 34.34 - 34.54
52wk Range 27.95 - 43.32
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday. 
Via Benzinga
Exposures COVID-19
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation
Via Investor Brand Network
Exposures Product Safety

Performance

YTD
-12.32%
-12.32%
1 Month
-3.70%
-3.70%
3 Month
-10.03%
-10.03%
6 Month
-1.68%
-1.68%
1 Year
-14.12%
-14.12%

More News

Read More
Pathways to Progress: How Orphan Drug Designation Sparks Biotech Transformation
Via FinancialNewsMedia
Exposures Product Safety
Buy List Alert: 3 Pharma Stocks with Positive Trial Updates
Via InvestorPlace
2 Growth Stocks That Could Rocket 88% to 99% Higher According to Wall Street
Via The Motley Fool
AI Integration In Biotech & Pharma: Companies Positioned To Benefit
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Global Dry Eye Syndrome Treatment Market Expected to Reach $11.26 Billion By 2030
Via FinancialNewsMedia
Exposures COVID-19
Hypertension Impacts 1.2B People - Alnylam's Gene Silencing Drug Candidate Hits the Mark in Phase 2 Study, Offering Hope
Via Benzinga
FDA Accepts Application for Genentech’s Crovalimab for the Treatment of PNH, a Rare Life-Threatening Blood Condition
From Genentech
Via Business Wire
Roche's Approved Lung Cancer Drug Beats Chemo In Rare Type Of Lung Cancer
Via Benzinga
Genentech’s Alecensa Delivers Unprecedented Phase III Results for People With ALK-Positive Early-Stage Lung Cancer
From Genentech
Via Business Wire
Cancer Treatment In 7 Minutes: UK's Health Service To Rollout Roche's Tencentriq Injection Cutting Treatment Time
Via Benzinga
3 Up-and-Coming Biotech Stocks to Put on Your Must-Buy List
Via InvestorPlace
Who Are Other Players Gaining From Roche's Accidental Lung Cancer Data Update
Via Benzinga
How Roche's Accidental Cancer Update Lifted Iteos And Arcus More Than 30%
Via Investor's Business Daily
Roche's Accidental Lung Cancer Trial Data Leak: Shows Encouraging Early Data From Combination Therapy Study
Via Benzinga
Genentech Provides Update on Phase III SKYSCRAPER-01 Study in PD-L1-High Metastatic Non-Small Cell Lung Cancer
From Genentech
Via Business Wire
Regeneron's Crucial Eylea HD Approval: A Shield Against Potential Biosimilar Competition?
Via Benzinga
Exposures Product Safety
Third Time Lucky: Exelixis' Cabozantinib Combo Therapy Aces Pivotal Study In Prostate Cancer Patients
Via Benzinga
Is Regeneron Pharmaceuticals Still a Top Growth Stock?
Via The Motley Fool
What's Going On With Sonnet BioTherapeutics Stock Today?
Via Benzinga
Top Biotech Roivant, Formed By Vivek Ramaswamy, Reports Steep Losses, Light Sales
Via Investor's Business Daily
Is TTOO Stock Really Worth $5? Or Just 5 Cents?
Via InvestorPlace
Is AbbVie Still a Good Dividend Stock to Buy?
Via The Motley Fool
Why Is Aravive Stock Sinking Today?
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.